Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Cytokinetics Inc. buy Morgan Stanley

Cytokinetics Inc.
Start price
€41.00
13.02.25 / 50%
Target price
€64.45
13.02.26
Performance (%)
26.83%
Price
€52.00
10.12.25
Summary
This prediction is currently active. The prediction currently has a performance of 26.83%. This prediction currently runs until 13.02.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Cytokinetics Inc. -6.306% -6.306%
iShares Core DAX® 1.803% 0.496%
iShares Nasdaq 100 0.429% -0.410%
iShares Nikkei 225® 0.708% -3.799%
iShares S&P 500 0.288% -0.218%

Comments by Morgan_Stanley for this prediction

In the thread Discuss Cytokinetics Inc.
Prediction Buy
Perf. (%) 26.83%
Target price 64.454
Change
Ends at 13.02.26

Cytokinetics, Incorporated (NASDAQ: CYTK) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $67.00 price target on the stock, down previously from $70.00.
Ratings data for CYTK provided by MarketBeat

Morgan Stanley 
0
Report Share
13.02.25

Stopped prediction by Morgan_Stanley for Cytokinetics Inc.

buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€30.20
04.08.23
€54.39
04.08.24
67.22%
05.08.24

Morgan Stanley 
04.08.23 50%